- Home
- SANG vs TVGN Comparison
SANG vs TVGN Comparison
Compare SANG & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANG
- TVGN
- Stock Information
- Founded
- SANG 1984
- TVGN 2020
- Country
- SANG Canada
- TVGN United States
- Employees
- SANG N/A
- TVGN N/A
- Industry
- SANG Computer Software: Programming Data Processing
- TVGN Blank Checks
- Sector
- SANG Technology
- TVGN Finance
- Exchange
- SANG Nasdaq
- TVGN Nasdaq
- Market Cap
- SANG 194.3M
- TVGN 179.0M
- IPO Year
- SANG 2021
- TVGN N/A
- Fundamental
- Price
- SANG $5.50
- TVGN $0.87
- Analyst Decision
- SANG
- TVGN Strong Buy
- Analyst Count
- SANG 0
- TVGN 1
- Target Price
- SANG N/A
- TVGN $10.00
- AVG Volume (30 Days)
- SANG 2.1K
- TVGN 663.2K
- Earning Date
- SANG 11-05-2025
- TVGN 08-14-2025
- Dividend Yield
- SANG N/A
- TVGN N/A
- EPS Growth
- SANG N/A
- TVGN N/A
- EPS
- SANG N/A
- TVGN N/A
- Revenue
- SANG $238,264,000.00
- TVGN N/A
- Revenue This Year
- SANG N/A
- TVGN N/A
- Revenue Next Year
- SANG $2.38
- TVGN N/A
- P/E Ratio
- SANG N/A
- TVGN N/A
- Revenue Growth
- SANG N/A
- TVGN N/A
- 52 Week Low
- SANG $4.08
- TVGN $0.26
- 52 Week High
- SANG $7.99
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- SANG 40.38
- TVGN 33.67
- Support Level
- SANG $5.57
- TVGN $0.85
- Resistance Level
- SANG $6.26
- TVGN $0.95
- Average True Range (ATR)
- SANG 0.11
- TVGN 0.05
- MACD
- SANG -0.01
- TVGN 0.00
- Stochastic Oscillator
- SANG 6.17
- TVGN 10.63
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.